Abveris is a leading antibody discovery partner based in Boston and operates as a division of Twist Bioscience. Established in 2014, the company specializes in in vivo antibody discovery and collaborates with top biopharmaceutical scientists across various organizations. Their efforts focus on discovering and developing antibodies for pharmaceutical and industrial applications within the Biopharma, Biotechnology, and Pharmaceutical industries. Currently, there is no public information available regarding their latest investment round or investors.
General Information
Get notified when Abveris moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Abveris
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
United States Market
Biopharma
About Abveris
Taxonomy: Antibody Discovery, Anti-Idiotype Antibodies, Hybridoma Discovery, Antibody Therapeutics, In Vivo Discovery, Reagent Antibodies
No funding data available for Abveris yet.
Get notified when Abveris raises fundingAbveris Alternatives & Competitors
A superior, next generation transgenic platform.
Discovery and development of novel and safer antibody-based therapeutics.
FAQ About Abveris
Don't just browse. Track.
Signal Tracker monitors Abveris and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.